Emergent BioSolutions EBS
NYSE EBS
$6.76 +0.21 (+3.21%)
At close: Sep 22, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Payables (2010 - 2026)

Emergent BioSolutions (EBS) posted Payables of $50.2 million for Q2 2026, up 27.09% on a QoQ basis from $39.5 million in Q1 2026, and down 21.19% year-over-year from $63.7 million in Q2 2025.

Analysis

Emergent BioSolutions (EBS) Payables (2010 - 2026) Analysis & Trends

Emergent BioSolutions has reported Payables for 17 years, with the latest figure at $50.2 million in Q2 2026.

  • On a quarterly basis, Payables fell 21.19% year-over-year to $50.2 million in Q2 2026; TTM through Jun 2026 was $50.2 million, a 21.19% decrease from a year earlier, with the FY2025 full-year figure at $55.6 million, down 8.7% from the prior year.
  • Payables was $50.2 million for Q2 2026 at Emergent BioSolutions, up from $39.5 million in the prior quarter.
  • The five-year high for Payables was $1.1 billion in Q1 2023, with the low at $39.5 million in Q1 2026.
  • Average Payables over 5 years is $316.1 million, with a median of $130.0 million recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Payables surged 673.87% in 2023, then tumbled 89.61% in 2025.
  • Over 5 years, Payables stood at $1.1 billion in 2022, then tumbled by 50.42% to $525.9 million in 2023, then plunged by 88.42% to $60.9 million in 2024, then dropped by 8.7% to $55.6 million in 2025, then decreased by 9.71% to $50.2 million in 2026.
  • The last three Payables figures came in at $50.2 million (Q2 2026), $39.5 million (Q1 2026), and $55.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Johnson & Johnson 649.47 Bn 628.71 Bn 17.26 Bn 20.92 Bn
2 AbbVie 467.46 Bn 460.93 Bn 12.70 Bn 33.30 Bn
3 Merck 369.31 Bn 362.22 Bn 12.21 Bn 5.96 Bn
4 Novartis Ag 269.03 Bn 261.74 Bn 11.24 Bn 4.26 Bn
5 Pfizer 158.11 Bn 146.71 Bn 10.94 Bn 7.03 Bn
6 Bristol Myers Squibb 127.96 Bn 116.89 Bn 9.25 Bn 4.16 Bn
7 Sanofi 51.83 Bn 44.86 Bn 10.79 Bn 8.31 Bn
8 BeOne Medicines 41.33 Bn 36.23 Bn 1.53 Bn 470.30 Mn
9 Revolution Medicines 41.30 Bn 41.30 Bn - 88.42 Mn
10 Emergent BioSolutions 335.50 Mn 194.60 Mn 137.20 Mn 50.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 50.20 Mn
Mar 31, 2026 39.50 Mn
Dec 31, 2025 55.60 Mn
Sep 30, 2025 57.40 Mn
Jun 30, 2025 63.70 Mn
Mar 31, 2025 58.10 Mn
Dec 31, 2024 60.90 Mn
Sep 30, 2024 82.90 Mn
Jun 30, 2024 511.10 Mn
Mar 31, 2024 559.40 Mn
Dec 31, 2023 525.90 Mn
Sep 30, 2023 526.30 Mn
Jun 30, 2023 563.50 Mn
Mar 31, 2023 1.07 Bn
Dec 31, 2022 1.06 Bn
Sep 30, 2022 122.20 Mn
Jun 30, 2022 137.80 Mn
Mar 31, 2022 138.90 Mn
Dec 31, 2021 160.50 Mn
Sep 30, 2021 166.80 Mn
API Access

Emergent BioSolutions Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=EBS&period=max&api_key=YOUR_API_KEY